Non-epithelial ovarian cancer: Elucidating uncommon gynaecological malignancies

Anticancer Research

Volumn 36, Issue 10, 2016, Pages 5031-5042

  Boussios, Stergios ^a   Zarkavelis, George ^a   Seraj, Esmeralda ^a   Zerdes, Ioannis ^a   Tatsi, Konstantina ^b   Pentheroudakis, George ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

^b G HATZIKOSTA GENERAL HOSPITAL   (Greece)

Author keywords

Germ cell tumours; Review; Sex cord stromal tumours

Indexed keywords

ESTRADIOL; INHIBIN;

ANDROBLASTOMA; CANCER ADJUVANT THERAPY; CANCER CLASSIFICATION; CANCER HORMONE THERAPY; CANCER INCIDENCE; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CYTOREDUCTIVE SURGERY; DYSGERMINOMA; FEMALE; GERM CELL TUMOR; HUMAN; INTERVENTION STUDY; MULTICENTER STUDY (TOPIC); NON-EPITHELIAL TUMORS; OUTCOME ASSESSMENT; OVARY CARCINOMA; PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SALVAGE THERAPY; SARCOMA; SEX CORD STROMAL CELL TUMOR; SMALL CELL CARCINOMA; YOLK SAC TUMOR; NEOPLASMS, GERM CELL AND EMBRYONAL; OVARIAN NEOPLASMS; SEX CORD-GONADAL STROMAL TUMORS;

FEMALE; HUMANS; NEOPLASMS, GERM CELL AND EMBRYONAL; OVARIAN NEOPLASMS; SEX CORD-GONADAL STROMAL TUMORS;

EID: 84991771969     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: 10.21873/anticanres.11072     Document Type: Review

References (97)

1. Tavassoli FA and Deville P: Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Lyon, France: International Agency for Research on Cancer, pp. 163-179, 2003.
2. Lee-Jones L: Ovary: Germ cell tumors. Atlas Genet Cytogenet Oncol Haematol, 2003, available at http://atlasgenetics oncology.org/Tumors/OvarianGermCellID5067.html
3. Pectasides D, Pectasides E and Psyrri A: Granulosa cell tumor of the ovary. Cancer Treat Rev 34: 1-12, 2008.
4. Schumer ST and Cannistra SA: Granulosa cell tumor of the ovary. J Clin Oncol 21: 1180-1189, 2003.
5. Koulouris CR and Penson RT: Ovarian stromal and germ cell tumors. Semin Oncol 36: 126-136, 2009.
6. Parkinson CA, Hatcher HM and Ajithkumar TV: Management of malignant ovarian germ cell tumors. Obstet Gynecol Surv 66: 507-514, 2011.
7. Young RH, Goodman A, Penson RT, Russell AH, Uppot RN and Tambouret RH: Case records of the Massachusetts General Hospital. Case 8-2010. A 22-year-old woman with hypercalcemia and a pelvic mass. N Engl J Med 362: 1031-1040, 2010.
8. Eichhorn JH, Young RH and Scully RE: Primary ovarian small cell carcinoma of pulmonary type. A clinicopathologic, immunohistologic, and flow cytometric analysis of 11 cases. Am J Surg Pathol 16: 926-938, 1992.
9. Zalel Y, Piura B, Elchalal U, Czernobilsky B, Antebi S and Dgani R: Diagnosis and management of malignant germ cell ovarian tumors in young females. Int J Gynaecol Obstet 55: 1-10, 1996.
10. Gershenson DM, del Junco G, Silva EG, Copeland LJ, Wharton JT and Rutledge FN: Immature teratoma of the ovary. Obstet Gynecol 68: 624-629, 1986.
11. Gershenson DM: Management of ovarian germ cell tumors. J Clin Oncol 2007 25: 2938-2943, 2007.
12. Kodama M, Grubbs BH, Blake EA, Cahoon SS, Murakami R, Kimura T and Matsuo K: Feto-maternal outcomes of pregnancy complicated by ovarian malignant germ cell tumor: a systematic review of literature. Eur J Obstet Gynecol Reprod Biol 181: 145-156, 2014.
13. Cao D, Guo S, Allan RW, Molberg KH and Peng Y: SALL4 is a novel sensitive and specific marker of ovarian primitive germ cell tumors and is particularly useful in distinguishing yolk sac tumor from clear cell carcinoma. Am J Surg Pathol 33: 894-904, 2009.
14. Ushiku T, Shinozaki A, Shibahara J, Iwasaki Y, Tateishi Y, Funata N and Fukayama M: SALL4 represents fetal gut differentiation of gastric cancer, and is diagnostically useful in distinguishing hepatoid gastric carcinoma from hepatocellular carcinoma. Am J Surg Pathol 34: 533-540, 2010.
15. Scully RE, Young RH and Clement PB: Tumors of the Ovary, Maldeveloped Gonads, Fallopian Tube, and Broad Ligament. Third Series, Fascicle 23. Washington, DC: Armed Forces Institute of Pathology, 1998.
16. Colombo N, Peiretti M, Garbi A, Carinelli S, Marini C and Sessa C; ESMO Guidelines Working Group: Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 23: vii20-26, 2012.
17. Billmire DF, Cullen JW, Rescorla FJ, Davis M, Schlatter MG, Olson TA, Malogolowkin MH, Pashankar F, Villaluna D, Krailo M, Egler RA, Rodriguez-Galindo C and Frazier AL: Surveillance after initial surgery for pediatric and adolescent girls with stage I ovarian germ cell tumors: report from the Children's Oncology Group. J Clin Oncol 32: 465-470, 2014.
18. Smith HO, Berwick M, Verschraegen CF, Wiggins C, Lansing L, Muller CY and Qualls CR: Incidence and survival rates for female malignant germ cell tumors. Obstet Gynecol 107: 1075-1085, 2006.
19. Koi C, Kurita T, Kagami S, Matsuyaya A and Hachisuga T: A case of ovarian yolk sac tumor associated with endometrioid adenocarcinoma. Gynecol Oncol Case Rep 9: 11-14, 2014.
20. Maeda D, Ota S, Takazawa Y, Aburatani H, Nakagawa S, Yano T, Taketani Y, Kodama T and Fukayama M: Glypican-3 expression in clear cell adenocarcinoma of the ovary. Mod Pathol 22: 824-832, 2009.
21. Kurman RJ and Norris HJ: Malignant germ cell tumors of the ovary. Hum Pathol 8: 551-564, 1977.
22. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Ovarian Cancer. URL: http://www.nccn.org/professionals/physician-gls/f-guidelines.asp.
23. Patterson DM, Murugaesu N, Holden L, Seckl MJ and Rustin GJ: A review of the close surveillance policy for stage I female germ cell tumors of the ovary and other sites. Int J Gynecol Cancer 18: 43-50, 2008.
24. Williams SD, Blessing JA, DiSaia PJ, Major FJ, Ball HG 3rd and Liao SY: Second-look laparotomy in ovarian germ cell tumors: the gynecologic oncology group experience. Gynecol Oncol 52: 287-291, 1994.
25. Bentivegna E, Azaïs H, Uzan C, Leary A, Pautier P, Gonthier C, Genestie C, Balleyguier C, Lhomme C, Duvillard P, Morice P and Gouy S: surgical outcomes after debulking surgery for intraabdominal ovarian growing teratoma syndrome: Analysis of 38 cases. Ann Surg Oncol 22: S964-970, 2015.
26. Dimopoulos MA, Papadimitriou C, Hamilos G, Efstathiou E, Vlahos G, Rodolakis A, Aravantinos G, Kalofonos H, Kouroussis C, Gika D, Skarlos D and Bamias A: Treatment of ovarian germ cell tumors with a 3-day bleomycin, etoposide, and cisplatin regimen: a prospective multicenter study. Gynecol Oncol 95: 695-700, 2004.
27. Kondagunta GV, Bacik J, Donadio A, Bajorin D, Marion S, Sheinfeld J, Bosl GJ and Motzer RJ: Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors. J Clin Oncol 23: 6549-6555, 2005.
28. Billmire D, Vinocur C, Rescorla F, Cushing B, London W, Schlatter M, Davis M, Giller R, Lauer S and Olson T; Children's Oncology Group (COG): Outcome and staging evaluation in malignant germ cell tumors of the ovary in children and adolescents: an intergroup study. J Pediatr Surg 39: 424-429, 2004.
29. Solheim O, Gershenson DM, Tropé CG, Rokkones E, Sun CC, Weedon-Fekjaer H and Fosså SD: Prognostic factors in malignant ovarian germ cell tumours (The Surveillance, Epidemiology and End Results experience 1978-2010). Eur J Cancer 50: 1942-1950, 2014.
30. Solheim O, Tropé CG, Rokkones E, Kærn J, Paulsen T, Salvesen HB, Hagen B, Vereide AB and Fosså SD: Fertility and gonadal function after adjuvant therapy in women diagnosed with a malignant ovarian germ cell tumor (MOGCT) during the cisplatin era. Gynecol Oncol 136: 224-229, 2015.
31. Zanetta G, Bonazzi C, Cantù M, Binidagger S, Locatelli A, Bratina G and Mangioni C: Survival and reproductive function after treatment of malignant germ cell ovarian tumors. J Clin Oncol 19: 1015-1020, 2001.
32. Sklar CA, Mertens AC, Mitby P, Whitton J, Stovall M, Kasper C, Mulder J, Green D, Nicholson HS, Yasui Y and Robison LL: Premature menopause in survivors of childhood cancer: a report from the childhood cancer survivor study. J Natl Cancer Inst 98: 890-896, 2006.
33. Del Mastro L, Boni L, Michelotti A, Gamucci T, Olmeo N, Gori S, Giordano M, Garrone O, Pronzato P, Bighin C, Levaggi A, Giraudi S, Cresti N, Magnolfi E, Scotto T, Vecchio C and Venturini M: Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial. JAMA 306: 269-276, 2011.
34. Nichols CR, Breeden ES, Loehrer PJ, Williams SD and Einhorn LH: Secondary leukemia associated with a conventional dose of etoposide: review of serial germ cell tumor protocols. J Natl Cancer Inst 85: 36-40, 1993.
35. Zhang M, Cheung MK, Shin JY, Kapp DS, Husain A, Teng NN, Berek JS, Osann K and Chan JK: Prognostic factors responsible for survival in sex cord stromal tumors of the ovary-an analysis of 376 women. Gynecol Oncol 104: 396-400, 2007.
36. vanMeurs HS, Bleeker MC, van der Velden J, Overbeek LI, Kenter GG and Buist MR: The incidence of endometrial hyperplasia and cancer in 1031 patients with a granulosa cell tumor of the ovary: long-term follow-up in a population-based cohort study. Int J Gynecol Cancer 23: 1417-1422, 2013.
37. Gittleman AM, Price AP, Coren C, Akhtar M, Donovan V and Katz DS: Juvenile granulosa cell tumor. Clin Imaging 27: 221-224, 2003.
38. McCluggage WG: Immunoreactivity of ovarian juvenile granulosa cell tumours with epithelial membrane antigen. Histopathology 46: 235-236, 2005.
39. Jamieson S and Fuller PJ: Management of granulosa cell tumour of the ovary. Curr Opin Oncol 20: 560-564, 2008.
40. Sekkate S, Kairouani M, Serji B, Tazi A, Mrabti H, Boutayeb S and Errihani H: Ovarian granulosa cell tumors: a retrospective study of 27 cases and a review of the literature. World J Surg Oncol 2013 11: 142, 2013.
41. Shah SP, Köbel M, Senz J, Morin RD, Clarke BA, Wiegand KC, Leung G, Zayed A, Mehl E, Kalloger SE, Sun M, Giuliany R, Yorida E, Jones S, Varhol R, Swenerton KD, Miller D, Clement PB, Crane C, Madore J, Provencher D, Leung P, DeFazio A, Khattra J, Turashvili G, Zhao Y, Zeng T, Glover JN, Vanderhyden B, Zhao C, Parkinson CA, Jimenez-Linan M, Bowtell DD, Mes-Masson AM, Brenton JD, Aparicio SA, Boyd N, Hirst M, Gilks CB, Marra M and Huntsman DG: Mutation of FOXL2 in granulosa-cell tumors of the ovary. N Engl J Med 360: 2719-2729, 2009.
42. Rey RA, Lhommé C, Marcillac I, Lahlou N, Duvillard P, Josso N and Bidart JM: Antimüllerian hormone as a serum marker of granulosa cell tumors of the ovary: comparative study with serum alpha-inhibin and estradiol. Am J Obstet Gynecol 174: 958-965, 1996.
43. Robertson DM, Cahir N, Burger HG, Mamers P and Groome N: Inhibin forms in serum from postmenopausal women with ovarian cancers. Clin Endocrinol (Oxf) 50: 381-386, 1999.
44. Ranganath R, Sridevi V, Shirley SS and Shantha V: Clinical and pathologic prognostic factors in adult granulosa cell tumors of the ovary. Int J Gynecol Cancer 18: 929-933, 2008.
45. Wolf JK, Mullen J, Eifel PJ, Burke TW, Levenback C and Gershenson DM: Radiation treatment of advanced or recurrent granulosa cell tumor of the ovary. Gynecol Oncol 73: 35-41, 1999.
46. Savage P, Constenla D, Fisher C, Shepherd JH, Barton DP, Blake P and Gore ME: Granulosa cell tumours of the ovary: demographics, survival and the management of advanced disease. Clin Oncol 10: 242-245, 1998.
47. Hauspy J, Beiner ME, Harley I, Rosen B, Murphy J, Chapman W, Le LW, Fyles A and Levin W: Role of adjuvant radiotherapy in granulosa cell tumors of the ovary. Int J Radiat Oncol Biol Phys 79: 770-774, 2011.
48. E C, Samant R, Fung MF, Le T, Hopkins L and Senterman M: Palliative radiotherapy for recurrent granulosa cell tumor of the ovary: a report of 3 cases with radiological evidence of response. Gynecol Oncol 102: 406-410, 2006.
49. Zambetti M, Escobedo A, Pilotti S and De Palo G: cisplatinum/vinblastine/bleomycin combination chemotherapy in advanced or recurrent granulosa cell tumors of the ovary. Gynecol Oncol 36: 317-320, 1990.
50. Brown J, Shvartsman HS, Deavers MT, Ramondetta LM, Burke TW, Munsell MF and Gershenson DM: The activity of taxanes compared with bleomycin, etoposide, and cisplatin in the treatment of sex cord-stromal ovarian tumors. Gynecol Oncol 97: 489-496, 2005.
51. Alexiadis M, Eriksson N, Jamieson S, Davis M, Drummond AE, Chu S, Clyne CD, Muscat GE and Fuller PJ: Nuclear receptor profiling of ovarian granulosa cell tumors. Horm Cancer 2: 157-169, 2011.
52. van Meurs HS, van Lonkhuijzen LR, Limpens J, van der Velden J and Buist MR: Hormone therapy in ovarian granulosa cell tumors: a systematic review. Gynecol Oncol 134: 196-205, 2014.
53. Roth LM: Recent advances in the pathology and classification of ovarian sex cord-stromal tumors. Int J Gynecol Pathol 25: 199-215, 2006.
54. Juri G, Zarkovi N, Nola M, Tillian M and Juki S: The value of cell proliferation and angiogenesis in the prognostic assessment of ovarian granulosa cell tumors. Tumori 87: 47-53, 2001.
55. Gebhart JB, Roche PC, Keeney GL, Lesnick TG and Podratz KC: Assessment of inhibin and p53 in granulosa cell tumors of the ovary. Gynecol Oncol 77: 232-236, 2000.
56. Kurtz JE, Jaeck D, Maloisel F, Jung GM, Chenard MP and Dufour P: Combined modality treatment for malignant transformation of a benign ovarian teratoma. Gynecol Oncol 73: 319-321, 1999.
57. Nouriani M, Felix JC and Dubeau L: Histogenesis and histopathological characteristics of Sertoli-Leydig cell tumors. CME J Gynecol Oncol 7: 114-120, 2002.
58. Rekhi B, Karpate A, Deodhar KK and Chinoy RF: Metastatic rhabdomyosarcomatous elements, mimicking a primary sarcoma, in the omentum, from a poorly differentiated ovarian Sertoli-Leydig cell tumor in a young girl: an unusual presentation with a literature review. Indian J Pathol Microbiol 52: 554-558, 2009.
59. McCluggage WG, McKenna M and McBride HA: CD56 is a sensitive and diagnostically useful immunohistochemical marker of ovarian sex cord-stromal tumors. Int J Gynecol Pathol 26: 322-327, 2007.
60. McCluggage WG and Young RH: Immunohistochemistry as a diagnostic aid in the evaluation of ovarian tumors. Semin Diagn Pathol 22: 3-32, 2005.
61. Brown J, Sood AK, Deavers MT, Milojevic L and Gershenson DM: Patterns of metastasis in sex cord-stromal tumors of the ovary: Can routine staging lymphadenectomy be omitted? Gynecol Oncol 113: 86-90, 2009.
62. Ray-Coquard I, Brown J, Harter P, Provencher DM, Fong PC, Maenpaa J, Ledermann JA, Emons G, Rigaud DB, Glasspool RM, Mezzanzanica D and Colombo N: Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian sex cord stromal tumors. Int J Gynecol Cancer 24: S42-47, 2014.
63. Colombo N, Parma G, Zanagnolo V and Insinga A: Management of ovarian stromal cell tumors. J Clin Oncol 25: 2944-2951, 2007.
64. Lantzsch T, Stoerer S, Lawrenz K, Buchmann J, Strauss HG and Koelbl H: Sertoli-Leydig cell tumor. Arch Gynecol Obstet 264: 206-208, 2001.
65. Dykgraaf RH, de Jong D, van Veen M, Ewing-Graham PC, Helmerhorst TJ and van der Burg ME: Clinical management of ovarian small-cell carcinoma of the hypercalcemic type: a proposal for conservative surgery in an advanced stage of disease. Int J Gynecol Cancer 19: 348-353, 2009.
66. Foulkes WD, Clarke BA, Hasselblatt M, Majewski J, Albrecht S and McCluggage WG: No small surprise-small cell carcinoma of the ovary, hypercalcaemic type, is a malignant rhabdoid tumour. J Pathol 233: 209-214, 2014.
67. Harrison ML, Hoskins P, du Bois A, Quinn M, Rustin GJ, Ledermann JA, Baron-Hay S and Friedlander ML: Small cell of the ovary, hypercalcemic type-analysis of combined experience and recommendation for management. A GCIG study. Gynecol Oncol 100: 233-238, 2006.
68. Reed NS, Pautier P, Åvall-Lundqvist E, Choi CH, du Bois A, Friedlander M, Fyles A, Kichenadasse G, Provencher DM and Ray-Coquard I: Gynecologic Cancer Inter Group (GCIG) consensus review for ovarian small cell cancers. Int J Gynecol Cancer 24: S30-34, 2014.
69. Young RH, Oliva E and Scully RE: Small cell carcinoma of the ovary, hypercalcemic type. A clinicopathological analysis of 150 cases. Am J Surg Pathol 18: 1102-1116, 1994.
70. Berton-Rigaud D, Devouassoux-Shisheboran M, Ledermann JA, Leitao MM, Powell MA, Poveda A, Beale P, Glasspool RM, Creutzberg CL, Harter P, Kim JW, Reed NS and Ray-Coquard I: Gynecologic Cancer InterGroup (GCIG) consensus review for uterine and ovarian carcinosarcoma. Int J Gynecol Cancer 24: S55-60, 2014.
71. Gershenson DM, Copeland LJ, Kavanagh JJ, Stringer CA, Saul PB and Wharton JT: Treatment of metastatic stromal tumors of the ovary with cisplatin, doxorubicin, and cyclophosphamide. Obstet Gynecol 70: 765-769, 1987.
72. Pecorelli S, Wagenaar HC, Vergote IB, Curran D, Beex LV, Wiltshaw E and Vermorken JB: Cisplatin (P), vinblastine (V) and bleomycin (B) combination chemotherapy in recurrent or advanced granulosa(-theca) cell tumours of the ovary. An EORTC Gynaecological Cancer Cooperative Group study. Eur J Cancer 35: 1331-1337, 1999.
73. Pectasides D, Alevizakos N and Athanassiou AE: Cisplatincontaining regimen in advanced or recurrent granulosa cell tumours of the ovary. Ann Oncol 3: 316-318, 1992.
74. Gershenson DM, Morris M, Burke TW, Levenback C, Matthews CM and Wharton JT: Treatment of poor-prognosis sex cordstromal tumors of the ovary with the combination of bleomycin, etoposide, and cisplatin. Obstet Gynecol 87: 527-531, 1996.
75. Homesley HD, Bundy BN, Hurteau JA and Roth LM: Bleomycin, etoposide, and cisplatin combination therapy of ovarian granulosa cell tumors and other stromal malignancies: A Gynecologic Oncology Group study. Gynecol Oncol 72: 131-137, 1999.
76. Al-Badawi IA, Brasher PM, Ghatage P, Nation JG, Schepansky A and Stuart GC: Postoperative chemotherapy in advanced ovarian granulosa cell tumors. Int J Gynecol Cancer 12: 119-123, 2002.
77. Uygun K, Aydiner A, Saip P, Basaran M, Tas F, Kocak Z, Dincer M and Topuz E: Granulosa cell tumor of the ovary: retrospective analysis of 45 cases. Am J Clin Oncol 26: 517-521, 2003.
78. Pectasides D, Papaxoinis G, Fountzilas G, Aravantinos G, Pectasides E, Mouratidou D, Economopoulos T and Andreadis Ch: Adult granulosa cell tumors of the ovary: a clinicopathological study of 34 patients by the Hellenic Cooperative Oncology Group (HeCOG). Anticancer Res 28: 1421-1427, 2008.
79. Pautier P, Gutierrez-Bonnaire M, Rey A, Sillet-Bach I, Chevreau C, Kerbrat P, Morice P, Duvillard P and Lhommé C: Combination of bleomycin, etoposide, and cisplatin for the treatment of advanced ovarian granulosa cell tumors. Int J Gynecol Cancer 18: 446-452, 2008.
80. van Meurs HS, Buist MR, Westermann AM, Sonke GS, Kenter GG and van der Velden J: Effectiveness of chemotherapy in measurable granulosa cell tumors: a retrospective study and review of literature. Int J Gynecol Cancer 24: 496-505, 2014.
81. Malik ST and Slevin ML: Medroxyprogesterone acetate (MPA) in advanced granulosa cell tumours of the ovary-a new therapeutic approach? Br J Cancer 63: 410-411, 1991.
82. Isaacs R, Forgeson G and Allan S: Progestagens for granulosa cell tumours of the ovary. Br J Cancer 65: 140, 1992.
83. Kauppila A, Bangah M, Burger H and Martikainen H: GnRH agonist analog therapy in advanced/recurrent granulosa cell tumors: further evidence of a role of inhibin in monitoring response to treatment. Gynecol Endocrinol 6: 271-274, 1992.
84. Maxwell GL, Soisson AP and Miles P: Failure of gonadotropin releasing hormone therapy in patients with metastatic ovarian sex cord stromal tumors. Oncology 51: 356-359, 1994.
85. Fishman A, Kudelka AP, Tresukosol D, Edwards CL, Freedman RS, Kaplan AL, Girtanner RE, Kavanagh JJ. Leuprolide acetate for treating refractory or persistent ovarian granulosa cell tumor. J Reprod Med 41: 393-396, 1996.
86. Briasoulis E, Karavasilis V and Pavlidis N: Megestrol activity in recurrent adult type granulosa cell tumour of the ovary. Ann Oncol 8: 811-812, 1997.
87. Crew KD, Cohen MH, Smith DH, Tiersten AD, Feirt NM and Hershman DL: Long natural history of recurrent granulosa cell tumor of the ovary 23 years after initial diagnosis: a case report and review of the literature. Gynecol Oncol 96: 235-240, 2005.
88. Ameryckx L, Fatemi HM, De Sutter P and Amy JJ : GnRH antagonist in the adjuvant treatment of a recurrent ovarian granulosa cell tumor: a case report. Gynecol Oncol 99: 764-766, 2005.
89. Hardy RD, Bell JG, Nicely CJ and Reid GC: Hormonal treatment of a recurrent granulosa cell tumor of the ovary: case report and review of the literature. Gynecol Oncol 96: 865-869, 2005.
90. Freeman SA, Modesitt SC. Anastrozole therapy in recurrent ovarian adult granulosa cell tumors: a report of 2 cases. Gynecol Oncol 103: 755-758, 2006.
91. Korach J, Perri T, Beiner M, Davidzon T, Fridman E and Ben-Baruch G: Promising effect of aromatase inhibitors on recurrent granulosa cell tumors. Int J Gynecol Cancer 19: 830-833, 2009.
92. Kim HJ, Lee SC, Bae SB, Kwon KW, Kim CK, Lee NS, Lee KT, Won JH, Hong DS and Park HS: GnRH agonist therapy in a patient with recurrent ovarian granulosa cell tumors. J Korean Med Sci 24: 535-538, 2009.
93. Teoh D, Freedman R and Soliman PT: Nearly 30 years of treatment for recurrent granulosa cell tumor of the ovary: a case report and review of the literature. Case Rep Oncol 3: 14-18, 2010.
94. Abdul Munem A, Al-Bahrani B, Mehdi I, Kamona A and Nadas AM: Aromatase inhibitors-a viable option for recurrent granulosa cell tumour of ovary: overview and case report. J Pak Med Assoc 62: 505-507, 2012.
95. Alhilli MM, Long HJ, Podratz KC and Bakkum-Gamez JN: Aromatase inhibitors in the treatment of recurrent ovarian granulosa cell tumors: brief report and review of the literature. J Obstet Gynaecol Res 38: 340-344, 2012.
96. Keskin S, Bengisu E, Tuzlali S and Aydiner A: Complete response in a patient with granulosa cell tumor treated with a combination of leuprolide and tamoxifen. Onkologie 35: 451-453, 2012.
97. Kourie HR, Kattan J, Antoun J and Sleilaty F: Letrozole efficacy in the treatment of granulosa cell tumor of the ovary: a case report. Onkologie 36: 498-500, 2013.